The largest database of trusted experimental protocols

Anti gfap antibody

Manufactured by Santa Cruz Biotechnology
Sourced in United States

The Anti-GFAP antibody is a laboratory reagent used for the detection and analysis of the Glial Fibrillary Acidic Protein (GFAP) in biological samples. GFAP is an intermediate filament protein that is primarily expressed in astrocytes and other glial cells in the central nervous system. The Anti-GFAP antibody can be utilized in various experimental techniques, such as immunohistochemistry, western blotting, and flow cytometry, to study the expression and localization of GFAP in different cell types and tissue samples.

Automatically generated - may contain errors

7 protocols using anti gfap antibody

1

Immunofluorescence Staining of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brain sections were processed for immunofluorescence staining as previously described [46 (link)] and reported below. In brief, all sections were incubated overnight (O/N) in a humidified chamber at 37 °C using the following primary antibodies: anti-GFAP antibody (1:100; sc-33673; Santa Cruz Biotechnology), anti-IBA1 antibody (1:100; sc-32725; Santa Cruz Biotechnology). Sections were washed with PBS solution and incubated with IgG (H + L) highly cross-adsorbed goat anti-mouse secondary antibody, Alexa Fluor™ (1:1000 in PBS v/v, Molecular Probes, Altrincham, UK) for 1 h at 37 °C. After washing in PBS, nuclear staining with 4′,6′-diamidino-2-phenylindole (DAPI; Hoechst, Frankfurt, Germany) (2 µg/mL) in PBS was added. Slides were observed and photographed at 40× magnifications using a Leica DM2000 microscope (Leica QWin V3, Cambridge, UK).
+ Open protocol
+ Expand
2

Primary Astrocyte Isolation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary astrocytes were prepared according to previous study with modifications [23 (link), 24 (link)]. Briefly, cortex was dissected from postnatal day 0-1 C57BL/6 mouse pups. Cells were seeding in normal glucose Dulbecco’s Modified Eagle Medium (DMEM) with 10% Fetal Bovine Serum (FBS). Cells were then cultured CO2 incubators with medium changed every 2-3 days. When cells became confluent, plate was shaken on an orbital shaker. Then, medium was removed, and cells were split into new plates and culture for 2-7 days. These cells were then seeded and used for experiments. Propidium iodide (PI), annexin V, rotenone, carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP), and oligomycin were purchased from Sigma. Anti-GFAP antibody and anti-actin antibody were purchased from Santa Cruz; all the other antibodies were purchased from Cell Signaling. Quantitative real-time PCR was carried out using SYBR Green PCR Master Mix (Promega) and 7300 Real-Time PCR System from Applied Biosystems.
+ Open protocol
+ Expand
3

GFAP Immunohistochemistry in Rabbit

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit polyclonal anti-GFAP antibody (1:1000; Santa Cruz biotechnology, Inc., USA) was used, with a 3-h incubation at 37 °C, on a Vectastain Universal Elite ABC kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions (counterstained with haematoxylin). Endogenous peroxidase was inactivated by incubation with 3% hydrogen peroxide for 5 min. For the control study to confirm the specificity of immunostaining, phosphate buffered saline (PBS) or normal rabbit serum was substituted for the primary antibody.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Brain Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical analysis was performed as already described [50 (link)]. Subsequently, the sections were incubated overnight with an anti-Bromodeoxyuridine (BrdU) antibody (1:100; Santa Cruz Biotechnology) or anti-MPO antibody (1:250; Santa Cruz Biotechnology) or anti-NRLP3 antibody (1:250; Santa Cruz Biotechnology) or anti-COX-2 antibody (1:250; Santa Cruz Biotechnology) or anti-Iba-1 antibody (1:250; Santa Cruz Biotechnology) or anti-GFAP antibody (1:450; Santa Cruz Biotechnology). Sections were washed with PBS and incubated with peroxidase-conjugated bovine anti-mouse IgG, secondary antibody (1:2000 Jackson Immuno Research, West Grove, PA, USA). Specific labeling was provided with a biotin-conjugated goat anti-mouse IgG and avidin-biotin peroxidase complex (Vector Laboratories, Burlingame, CA, USA). Images were collected using a Leica DM6 microscope associated with Leica LAS X Navigator software. The number of positive cells was counted in three sections per animal and presented as the number of positive cells per high-power field.
+ Open protocol
+ Expand
5

Astrocytic Activation Analysis by GFAP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The astrocytes activation was assessed by immunofluorescence assay of the glial fibrillary acidic protein (GFAP), a major component of the cytoskeleton of astrocytes. Animals from each group (n = 6) were euthanized with CO2 on day 3 of medication administration. The brain tissues were collected and fixed. Transverse brain sections were obtained and processed as described previously for immunofluorescence assay.31 (link) Sections were incubated in 0.3% Triton X-100 containing 2% goat serum over 1 hour at room temperature and then over 48 hours at 4°C with anti-GFAP antibody (1:250; Santa Cruz Biotechnology, Inc, Santa Cruz, CA), followed by incubation for 1 hour with Alexa 488-conjugated secondary antibody (1:300; Santa Cruz Biotechnology, Inc) at room temperature. Tissue sections were imaged for green fluorescence by Olympus microscope (Olympus Co, Tokyo, Japan) and analyzed by pixel intensity profile using ImageJ 1.48v software (National Institutes of Health, Bethesda, MD). After subtracting the background signal, the ratio of mean pixel intensity (arbitrary units) of each group to naive group was calculated.
+ Open protocol
+ Expand
6

Histopathological Assessment of Hippocampal Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histopathological examinations, hippocampal tissue specimens were fixed in buffered neutral formalin (10%). Hippocampal specimens were dehydrated, embedded in paraffin, and sectioned (4–5 µm). Sections were stained using hematoxylin and eosin (H&E) and analyzed using a Nikon Eclipse E200-LED microscope (Tokyo, Japan, 200x and 400× magnification). The degree of hippocampal damage was characterized using a semi-quantitative scoring system, with five grades assigned according to the severity of injury, as follows: 1, minimal injury (<1%); 2, slight injury (1%–25%); 3, moderate injury (26%–50%); 4, moderate/severe injury (51%–75%); and 5, severe injury (76%–100%).47 (link) To detect glial fibrillary acidic protein (GFAP), hippocampal tissue sections were incubated overnight with an anti-GFAP antibody (Santa Cruz, CA, USA) at 4°C, followed by incubation with biotinylated secondary antibody at room temperature for 1-h. The 3,3ʹ-diaminobenzidine (DAB) peroxidase substrate kit was used to develop a brown color. The images were observed at a magnification of 400×, using a Nikon Eclipse E200 LED (Tokyo, Japan).
+ Open protocol
+ Expand
7

Glioma Cell Line Propagation and Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87MG glioma cell line was purchased from the American Tissue Culture Collection (Rockville, MD). These cell lines were propagated in RPMI (Invitrogen, Carlsbad, CA), with 10% FBS (Hyclone) and 1% penicillin/streptomycin as described before [25 (link)]. Antibodies against phospho-AKT (ser473), AKT, PTEN, phospho-ERK (p42/44 MAP kinase; Thr202/Tyr204), ERK (p42/44 MAP kinase) and PCNA were purchased from Cell Signaling Technology (Beverly, MA). Tubulin and anti-CD31 antibodies were procured from BD Biosciences (San Jose, CA). Anti-GFAP antibody, rabbit ImmunoCruz Staining system, mouse ImmunoCruz Staining system and rat ABC staining system were procured from Santa Cruz Biotechnology, Inc, (Santa Cruz, CA). LY294002 and PD98059 were purchased from Calbiochem (San Diego, CA). Vitronectin, β-actin and X-gal were purchased from Sigma-Aldrich, St. Louis, MO. RGDS was procured from Biomol International (Plymouth, PA). HRP-tagged anti-rabbit IgG and anti-mouse IgG were obtained from Amersham Life Sciences (UK). Goat anti-mouse and anti-rabbit IgG (H + L)-AP (human adsorbed) were purchased from Southern Biotechnology, Inc. (Birmingham, Alabama). SF1126 is a vascular targeted pan PI-3 kinase drug developed in collaboration with SignalRx pharmaceuticals.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!